Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds

Pharmacological Research

Volumn 103, Issue , 2016, Pages 80-94

  Denzer, Isabel ^a   Münch, Gerald ^b   Friedland, Kristina ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Aging; Mitochondrial dysfunction; Nrf2; Nutrition; Oxidative stress

Indexed keywords

CINNAMON EXTRACT; CURCUMIN; DEHYDROGLYASPERIN C; GENISTEIN; ISOLIQUIRITIGENIN; LYCOPENE; RESVERATROL; ROTENONE; S ALLYLCYSTEINE; SHOGAOL; SOLID LIPID NANOPARTICLE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; XANTHOHUMOL;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BROCCOLI; CELL PROTECTION; CLINICAL FEATURE; COFFEE; COGNITIVE DEFECT; CONCENTRATION RESPONSE; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG CLASSIFICATION; DRUG MECHANISM; DRUG STRUCTURE; FOOD INTAKE; GLYCYRRHIZA; HUMAN; LIPID PEROXIDATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; FOOD; METABOLISM; MITOCHONDRION;

ANIMALS; FOOD; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84949591390     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.11.019     Document Type: Review

References (182)

1. M.P. Mattson, and T. Magnus Ageing and neuronal vulnerability Nat. Rev. Neurosci. 7 2006 278 294
2. A. Johri, and M.F. Beal Mitochondrial dysfunction in neurodegenerative diseases J. Pharmacol. Exp. Ther. 342 2012 619 630
3. I. Matic, D. Strobbe, M. Frison, and M. Campanella Controlled and impaired mitochondrial quality in neurons: molecular physiology and prospective pharmacology Pharmacol. Res. 99 2015 410 424
4. W.E. Mueller, A. Eckert, C. Kurz, G.P. Eckert, and K. Leuner Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects Mol. Neurobiol. 41 2010 159 171
5. B.J. Ryan, S. Hoek, E.A. Fon, and R. Wade-Martins Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease Trends Biochem. Sci. 40 2015 200 210
6. P.H. Reddy Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission Drug Discov. Today 19 2014 951 955
7. H. Muyderman, and T. Chen Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target? Br. J. Pharmacol. 171 2014 2191 2205
8. M.M. Grabacka, M. Gawin, and M. Pierzchalska Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics Pharmaceuticals 7 2014 913 942
9. M.P. Mattson Mitochondrial regulation of neuronal plasticity Neurochem. Res. 32 2007 707 715
10. M.P. Mattson, M. Gleichmann, and A. Cheng Mitochondria in neuroplasticity and neurological disorders Neuron 60 2008 748 766
11. Y. Kushnareva, A.N. Murphy, and A. Andreyev Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state Biochem. J. 368 2002 545 553
12. A.Y. Andreyev, Y.E. Kushnareva, and A.A. Starkov Mitochondrial metabolism of reactive oxygen species Biochemistry (Moscow) 70 2005 200 214
13. M. Manczak, Y. Jung, B.S. Park, D. Partovi, and P.H. Reddy Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging J. Neurochem. 92 2005 494 504
14. K. Friedland-Leuner, C. Stockburger, I. Denzer, G.P. Eckert, and W.E. Muller Mitochondrial dysfunction: cause and consequence of Alzheimer's disease Prog. Mol. Biol. Transl. Sci. 127 2014 183 210
15. L. Pagani, and A. Eckert Amyloid-beta interaction with mitochondria Int. J. Alzheimer's Dis. 925050 2011 925012
16. R.X. Santos, S.C. Correia, X. Wang, G. Perry, and et al. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease J. Alzheimers Dis. 20 Suppl. 2 2010 S401 S412
17. D.D. Newmeyer, and S. Ferguson-Miller Mitochondria: releasing power for life and unleashing the machineries of death Cell 112 2003 481 490
18. R.A. Quintanilla, Y.N. Jin, R. von Bernhardi, and G.V.W. Johnson Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease Mol. Neurodegener. 8 2013 45
19. E. Giaime, E. Caballero, L. Núñez, Z. Song, and et al. Regulation of mitochondrial permeability transition pore by PINK1 Mol. Neurodegener. 7 2012 22
20. V.K. Rao, E.A. Carlson, and S.S. Yan Mitochondrial permeability transition pore is a potential drug target for neurodegeneration Biochim. Biophys. Acta 1842 2014 1267 1272
21. L.J. Martin The Mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy Biochim. Biophys. Acta 1802 2010 186 197
22. S. Rodriguez-Enriquez, L. He, and J.J. Lemasters Role of mitochondrial permeability transition pores in mitochondrial autophagy Int. J. Biochem. Cell Biol. 36 2004 2463 2472
23. 2+ in neurodegenerative disorders Pharmacol. Res. 99 2015 377 381
24. A.P. Halestrap What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 46 2009 821 831
25. T. Azarashvili, R. Stricker, and G. Reiser The mitochondria permeability transition pore complex in the brain with interacting proteins - promising targets for protection in neurodegenerative diseases Biol. Chem. 391 2010 619 629
26. A. Nunomura, G. Perry, G. Aliev, K. Hirai, and et al. Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767
27. K. Leuner, T. Schutt, C. Kurz, S.H. Eckert, and et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation Antioxid. Redox Signal. 16 2012 1421 1433
28. D.C. Wallace A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine Annu. Rev. Genet. 39 2005 359 407
29. O. Kann, and R. Kovacs Mitochondria and neuronal activity Am. J. Physiol. Cell Physiol. 292 2007 C641 C657
30. M. Cozzolino, S. Rossi, A. Mirra, and M.T. Carrì Mitochondrial dynamism and the pathogenesis of amyotrophic lateral sclerosis Front. Cell. Neurosci. 9 2015 31
31. M. Zaltieri, F. Longhena, M. Pizzi, and C. Missale Mitochondrial dysfunction and α-synuclein synaptic pathology in Parkinson's disease: who's on First? Parkinsons Dis. 2015 2015 108029
32. A. Johri, A. Chandra, and M.F. Beal PGC-1α, Mitochondrial dysfunction and Huntington's disease Free Radic. Biol. Med. 62 2013 37 46
33. S. Hoppins, L. Lackner, and J. Nunnari The machines that divide and fuse mitochondria Annu. Rev. Biochem. 76 2007 751 780
34. K. Itoh, K. Nakamura, M. Iijima, and H. Sesaki Mitochondrial dynamics in neurodegeneration Trends Cell Biol. 23 2013 64 71
35. E.A. Schon, and S. Przedborski Mitochondria: the next (neurode) generation Neuron 70 2011 1033 1053
36. D. Santos, A.R. Esteves, D. Silva, C. Januário, and S. Cardoso The impact of mitochondrial fusion and fission modulation in sporadic Parkinson's disease Mol. Neurobiol. 52 2015 573 586
37. S.A. Detmer, and D.C. Chan Functions and dysfunctions of mitochondrial dynamics Nat. Rev. Mol. Cell Biol. 8 2007 870 879
38. Y. Kageyama, Z. Zhang, and H. Sesaki Mitochondrial division: molecular machinery and physiological functions Curr. Opin. Cell Biol. 23 2011 427 434
39. Y. Yoon, E.W. Krueger, B.J. Oswald, and M.A. McNiven The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1 Mol. Cell. Biol. 23 2003 5409 5420
40. Y. Eura, N. Ishihara, S. Yokota, and K. Mihara Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion J. Biochem. 134 2003 333 344
41. S. Cipolat, O.M. de Brito, B. Dal Zilio, and L. Scorrano OPA1 requires mitofusin 1 to promote mitochondrial fusion Proc. Natl. Acad. Sci. U. S. A. 101 2004 15927 15932
42. X. Wang, B. Su, S.L. Siedlak, P.I. Moreira, and et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins Proc. Natl. Acad. Sci. U. S. A. 105 2008 19318 19323
43. X. Wang, B. Su, H.-g. Lee, X. Li, and et al. Impaired balance of mitochondria fission and fusion in Alzheimer disease J. Neurosci. 29 2009 9090 9103
44. Z. Jiang, W. Wang, G. Perry, X. Zhu, and X. Wang Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis Transl. Neurodegener. 4 2015 14
45. P. Kamat, A. Kalani, P. Kyles, S. Tyagi, and N. Tyagi Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease Cell Biochem. Biophys. 70 2014 707 719
46. M.J. Engelhart, M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, and et al. Dietary intake of antioxidants and risk of Alzheimer disease J. Am. Med. Assoc. 287 2002 3223 3229
47. R.K. Chaturvedi, and M.F. Beal Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases Mol. Cell. Neurosci. 55 2013 101 114
48. Y. Yang, S. Jiang, J. Yan, Y. Li, and et al. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders Cytokine Growth Factor Rev. 26 2015 47 57
49. T. Gura Hope in Alzheimer's fight emerges from unexpected places Nat. Med. 14 2008 894
50. G.P. Eckert, K. Renner, S.H. Eckert, and J. Eckmann Mitochondrial dysfunction - a pharmacological target in Alzheimer's disease Mol. Neurobiol. 46 2012 136 150
51. R. Abdel-Kader, S. Hauptmann, U. Keil, I. Scherping, and et al. Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761) Pharmacol. Res. 56 2007 493 502
52. X. Zhao, Y. Zou, H. Xu, L. Fan, and et al. Gastrodin protect primary cultured rat hippocampal neurons against amyloid-beta peptide-induced neurotoxicity via ERK1/2-Nrf2 pathway Brain Res. 1482 2012 13 21
53. C.J. Wruck, M.E. Gotz, T. Herdegen, D. Varoga, and et al. Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation Mol. Pharmacol. 73 2008 1785 1795
54. C. Lee, G.H. Park, S.R. Lee, and J.H. Jang Attenuation of beta-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2 Oxid. Med. Cell. Longev. 2013 2013 313510
55. K.U. Tufekci, E. Civi Bayin, S. Genc, and K. Genc The Nrf2/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease Parkinsons Dis. 2011 2011 314082
56. H. Kumar, H.W. Lim, S.V. More, B.W. Kim, and et al. The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism Int. J. Mol. Sci. 13 2012 10478 10504
57. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, and et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322
58. Y.J. Surh, J.K. Kundu, and H.K. Na Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals Planta Med. 74 2008 1526 1539
59. A.L. Eggler, K.A. Gay, and A.D. Mesecar Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2 Mol. Nutr. Food Res. 52 Suppl. 1 2008 S84 S94
60. T.M. Stepkowski, and M.K. Kruszewski Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis Free Radic. Biol. Med. 50 2011 1186 1195
61. M.J. Calkins, D.A. Johnson, J.A. Townsend, M.R. Vargas, and et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease Antioxid. Redox Signal. 11 2009 497 508
62. K.C. Wu, P.R. McDonald, J. Liu, and C.D. Klaassen Screening of natural compounds as activators of the Keap 1-Nrf2 pathway Planta Med. 80 2013 97 104
63. M.K. Kwak, K. Itoh, M. Yamamoto, T.R. Sutter, and T.W. Kensler Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent 3H-1, 2-dimethiole-3-thione Mol. Med. 7 2001 135 145
64. S.A. Chanas, Q. Jiang, M. McMahon, G.K. McWalter, and et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice Biochem. J. 365 2002 405 416
65. L. Baird, and A.T. Dinkova-Kostova The cytoprotective role of the Keap1-Nrf2 pathway Arch. Toxicol. 85 2011 241 272
66. H. Motohashi, and M. Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism Trends Mol. Med. 10 2004 549 557
67. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, and et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86
68. K. Itoh, K. Igarashi, N. Hayashi, M. Nishizawa, and M. Yamamoto Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins Mol. Cell. Biol. 15 1995 4184 4193
69. M.G. Marini, K. Chan, L. Casula, Y.W. Kan, and et al. hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2 J. Biol. Chem. 272 1997 16490 16497
70. F. Katsuoka, H. Motohashi, T. Ishii, H. Aburatani, and et al. Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes Mol. Cell. Biol. 25 2005 8044 8051
71. T.H. Rushmore, M.R. Morton, and C.B. Pickett The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity J. Biol. Chem. 266 1991 11632 11639
72. H.C. Huang, T. Nguyen, and C.B. Pickett Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 Proc. Natl. Acad. Sci. U. S. A. 97 2000 12475 12480
73. H.C. Huang, T. Nguyen, and C.B. Pickett Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription J. Biol. Chem. 277 2002 42769 42774
74. K.W. Kang, S.J. Lee, J.W. Park, and S.G. Kim Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress Mol. Pharmacol. 62 2002 1001 1010
75. D.A. Bloom, and A.K. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J. Biol. Chem. 278 2003 44675 44682
76. M. McMahon, N. Thomas, K. Itoh, M. Yamamoto, and J.D. Hayes Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron J. Biol. Chem. 279 2004 31556 31567
77. Y. Katoh, K. Itoh, E. Yoshida, M. Miyagishi, and et al. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription Genes Cells 6 2001 857 868
78. P. Nioi, T. Nguyen, P.J. Sherratt, and C.B. Pickett The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation Mol. Cell. Biol. 25 2005 10895 10906
79. Y. Li, and A.K. Jaiswal Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element J. Biol. Chem. 267 1992 15097 15104
80. T. Prestera, P. Talalay, J. Alam, Y.I. Ahn, and et al. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE) Mol. Med. 1 1995 827 837
81. J.M. Lee, M.J. Calkins, K. Chan, Y.W. Kan, and J.A. Johnson Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis J. Biol. Chem. 278 2003 12029 12038
82. T. Nguyen, C.S. Yang, and C.B. Pickett The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress Free Radic. Biol. Med. 37 2004 433 441
83. J.A. Johnson, D.A. Johnson, A.D. Kraft, M.J. Calkins, and et al. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration Ann. N. Y. Acad. Sci. 1147 2008 61 69
84. D.A. Johnson, G.K. Andrews, W. Xu, and J.A. Johnson Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice J. Neurochem. 81 2002 1233 1241
85. A.Y. Shih, D.A. Johnson, G. Wong, A.D. Kraft, and et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress J. Neurosci. 23 2003 3394 3406
86. A.D. Kraft, D.A. Johnson, and J.A. Johnson Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult J. Neurosci. 24 2004 1101 1112
87. K.M. Holmstrom, L. Baird, Y. Zhang, I. Hargreaves, and et al. Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration Biol. Open 2 2013 761 770
88. C.P. Ramsey, C.A. Glass, M.B. Montgomery, K.A. Lindl, and et al. Expression of Nrf2 in neurodegenerative diseases J. Neuropathol. Exp. Neurol. 66 2007 75 85
89. Y.N. Jin, Y.V. Yu, S. Gundemir, C. Jo, and et al. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant Huntingtin PLoS One 8 2013 e57932
90. G. Joshi, and J.A. Johnson The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases Recent Pat. CNS Drug Discov. 7 2012 218 229
91. A.T. Dinkova-Kostova, and A.Y. Abramov The emerging role of Nrf2 in mitochondrial function Free Radic. Biol. Med. 2015
92. T. Greco, and G. Fiskum Brain mitochondria from rats treated with sulforaphane are resistant to redox-regulated permeability transition J. Bioenerg. Biomembr. 42 2010 491 497
93. T. Greco, J. Shafer, and G. Fiskum Sulforaphane inhibits mitochondrial permeability transition and oxidative stress Free Radic. Biol. Med. 51 2011 2164 2171
94. D.M. Miller, I.N. Singh, J.A. Wang, and E.D. Hall Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo Free Radic. Biol. Med. 57 2013 1 9
95. K. Kanninen, T.M. Malm, H.K. Jyrkkanen, G. Goldsteins, and et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Mol. Cell. Neurosci. 39 2008 302 313
96. L. Yang, N.Y. Calingasan, B. Thomas, R.K. Chaturvedi, and et al. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription PloS One 4 2009 e5757
97. J.M. Lee, A.Y. Shih, T.H. Murphy, and J.A. Johnson NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons J. Biol. Chem. 278 2003 37948 37956
98. K. Kanninen, A.R. White, J. Koistinaho, and T. Malm Targeting glycogen synthase kinase-3beta for therapeutic benefit against oxidative stress in Alzheimer's disease: involvement of the Nrf2-ARE pathway Int. J. Alzheimer's Dis. 2011 2011 985085
99. W. Ma, L. Yuan, H. Yu, B. Ding, and et al. Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells Int. J. Dev. Neurosci. 28 2010 289 295
100. B. Eftekharzadeh, N. Maghsoudi, and F. Khodagholi Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons Biochimie 92 2010 245 253
101. A. Cheng, R. Wan, J.L. Yang, N. Kamimura, and et al. Involvement of PGC-1alpha in the formation and maintenance of neuronal dendritic spines Nat. Commun. 3 2012 1250
102. P. Puigserver, and B.M. Spiegelman Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator Endocr. Rev. 24 2003 78 90
103. U. Andersson, and R.C. Scarpulla Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells Mol. Cell. Biol. 21 2001 3738 3749
104. Z. Wu, P. Puigserver, U. Andersson, C. Zhang, and et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 98 1999 115 124
105. D. Knutti, and A. Kralli PGC-1, a versatile coactivator Trends Endocrinol. Metabol. 12 2001 360 365
106. P. Puigserver, Z. Wu, C.W. Park, and R. Graves A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 1998 829 839
107. J. Lin, C. Handschin, and B.M. Spiegelman Metabolic control through the PGC-1 family of transcription coactivators Cell Metabol. 1 2005 361 370
108. J.K. McGill, and M.F. Beal PGC-1alpha, a new therapeutic target in Huntington's disease? Cell 127 2006 465 468
109. R.K. Chaturvedi, and M. Flint Beal Mitochondrial diseases of the brain Free Radic. Biol. Med. 63 2013 1 29
110. D.P. Kelly, and R.C. Scarpulla Transcriptional regulatory circuits controlling mitochondrial biogenesis and function Genes Dev. 18 2004 357 368
111. B. Sheng, X. Wang, B. Su, H.-g. Lee, and et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease J. Neurochem. 120 2012 419 429
112. D.F. Silva, J.E. Selfridge, J. Lu, L. E, and et al. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines Hum. Mol. Genet. 22 2013 3931 3946
113. B. Zheng, Z. Liao, J.J. Locascio, K.A. Lesniak, and et al. PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease Sci. Transl. Med. 2 2010 52ra73
114. J.-H. Shin, H.S. Ko, H. Kang, Y. Lee, and et al. PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease Cell 144 2011 689 702
115. H. Liang, W.F. Ward, Y.C. Jang, A. Bhattacharya, and et al. PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model Muscle Nerve 44 2011 947 956
116. M. McMahon, K. Itoh, M. Yamamoto, S.A. Chanas, and et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes Cancer Res. 61 2001 3299 3307
117. Y. Li, J.D. Paonessa, and Y. Zhang Mechanism of chemical activation of Nrf2 PloS One 7 2012 e35122
118. A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, and et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol. Cell. Biol. 24 2004 7130 7139
119. D.D. Zhang Mechanistic studies of the Nrf2-Keap1 signaling pathway Drug Metabol. Rev. 38 2006 769 789
120. A.T. Dinkova-Kostova, W.D. Holtzclaw, and T.W. Kensler The role of Keap1 in cellular protective responses Chem. Res. Toxicol. 18 2005 1779 1791
121. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, and et al. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles Genes Cells 8 2003 379 391
122. N. Wakabayashi, A.T. Dinkova-Kostova, W.D. Holtzclaw, M.I. Kang, and et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers Proc. Natl. Acad. Sci. U. S. A. 101 2004 2040 2045
123. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, and et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. U. S. A. 99 2002 11908 11913
124. A.L. Eggler, G. Liu, J.M. Pezzuto, R.B. van Breemen, and A.D. Mesecar Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2 Proc. Natl. Acad. Sci. U. S. A. 102 2005 10070 10075
125. D.D. Zhang, S.C. Lo, J.V. Cross, D.J. Templeton, and M. Hannink Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex Mol. Cell. Biol. 24 2004 10941 10953
126. S.B. Cullinan, D. Zhang, M. Hannink, and E. Arvisais Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Mol. Cell. Biol. 23 2003 7198 7209
127. F. Hong, K.R. Sekhar, M.L. Freeman, and D.C. Liebler Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation J. Biol. Chem. 280 2005 31768 31775
128. M. Kobayashi, L. Li, N. Iwamoto, and Y. Nakajima-Takagi The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds Mol. Cell. Biol. 29 2009 493 502
129. A.T. Dinkova-Kostova, P. Talalay, J. Sharkey, Y. Zhang, and et al. An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1 J. Biol. Chem. 285 2010 33747 33755
130. S. Magesh, Y. Chen, and L. Hu Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents Med. Res. Rev. 32 2012 687 726
131. J.W. Fahey, Y. Zhang, and P. Talalay Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens Proc. Natl. Acad. Sci. U. S. A. 94 1997 10367 10372
132. F. Hong, M.L. Freeman, and D.C. Liebler Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane Chem. Res. Toxicol. 18 2005 1917 1926
133. A.T. Dinkova-Kostova, and P. Talalay Direct and indirect antioxidant properties of inducers of cytoprotective proteins Mol. Nutr. Food Res. 52 Suppl. 1 2008 S128 S138
134. A. Tarozzi, F. Morroni, A. Merlicco, S. Hrelia, and et al. Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line J. Neurochem. 111 2009 1161 1171
135. I. Denzer, G. Münch, M. Pischetsrieder, and K. Friedland S-allyl-l-cysteine and isoliquiritigenin improve mitochondrial function in cellular models of oxidative and nitrosative stress Food Chem. 194 2016 843 848
136. X. Zhai, M. Lin, F. Zhang, Y. Hu, and et al. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells Mol. Nutr. Food Res. 57 2013 249 259
137. T. Zhang, F. Wang, H.X. Xu, L. Yi, and et al. Activation of nuclear factor erythroid 2-related factor 2 and PPARgamma plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury Br. J. Nutr. 109 2013 223 235
138. Y.D. Xi, H.L. Yu, W.W. Ma, B.J. Ding, and et al. Genistein inhibits mitochondrial-targeted oxidative damage induced by beta-amyloid peptide 25-35 in PC12 cells J. Bioenerg. Biomembr. 43 2011 399 407
139. A. Frydman-Marom, A. Levin, D. Farfara, T. Benromano, and et al. Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models PloS One 6 2011 e16564
140. T.C. Huang, Y.L. Chung, M.L. Wu, and S.M. Chuang Cinnamaldehyde enhances Nrf2 nuclear translocation to upregulate phase II detoxifying enzyme expression in HepG2 cells J. Agric. Food Chem. 59 2011 5164 5171
141. R. Hamidpour, M. Hamidpour, S. Hamidpour, and M. Shahlari Cinnamon from the selection of traditional applications to its novel effects on the inhibition of angiogenesis in cancer cells and prevention of Alzheimer's disease, and a series of functions such as antioxidant, anticholesterol, antidiabetes, antibacterial, antifungal, nematicidal, acaracidal, and repellent activities J. Tradit. Complement. Med. 5 2015 66 70
142. Y.H. Kang, I.J. Yang, K.G. Morgan, and H.M. Shin Cinnamyl alcohol attenuates vasoconstriction by activation of K(+) channels via NO-cGMP-protein kinase G pathway and inhibition of Rho-kinase Exp. Mol. Med. 44 2012 749 755
143. M. Unlu, E. Ergene, G.V. Unlu, H.S. Zeytinoglu, and N. Vural Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum blume (Lauraceae) Food Chem. Toxicol. 48 2010 3274 3280
144. P.V. Rao, and S.H. Gan Cinnamon: a multifaceted medicinal plant Evid. Based Complement. Alternat. Med. 2014 2014 642942
145. D.W. Peterson, R.C. George, F. Scaramozzino, N.E. Lapointe, and et al. Cinnamon extract inhibits tau aggregation associated with alzheimer's disease in vitro J. Alzheimer's Dis. 17 2009 585 597
146. J.-H. Pyo, Y.-K. Jeong, S. Yeo, J.-H. Lee, and et al. Neuroprotective Effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury Biol. Pharm. Bull. 36 2013 1928 1935
147. H.J. Kim, S.S. Lim, I.S. Park, J.S. Lim, and et al. Neuroprotective Effects of Dehydroglyasperin C through Activation of Heme Oxygenase-1 in Mouse Hippocampal Cells J. Agric. Food Chem. 60 2012 5583 5589
148. J.Y. Seo, Y.S. Lee, H.J. Kim, S.S. Lim, and et al. Dehydroglyasperin C isolated from licorice caused Nrf2-mediated induction of detoxifying enzymes J. Agric. Food Chem. 58 2010 1603 1608
149. R. Motterlini, C.J. Green, and R. Foresti Regulation of heme oxygenase-1 by redox signals involving nitric oxide Antioxid. Redox Signal. 4 2002 615 624
150. J.Y. Seo, Y.S. Lee, H.J. Kim, S.S. Lim, and et al. Dehydroglyasperin C isolated from licorice caused Nrf2-mediated induction of detoxifying enzymes J. Agric. Food Chem. 58 2010 1603 1608
151. Y. Luo, A. Eggler, D. Liu, G. Liu, and et al. Sites of alkylation of human Keap1 by natural chemoprevention agents J. Am. Soc. Mass Spectrom. 18 2007 2226 2232
152. E.J. Yang, J.S. Min, H.Y. Ku, H.S. Choi, and et al. Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction Biochem. Biophys. Res. Commun. 421 2012 658 664
153. C.K. Hwang, and H.S. Chun Isoliquiritigenin isolated from licorice glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons Biosci. Biotechnol. Biochem. 76 2012 536 543
154. J.L. Barranco Quintana, M.F. Allam, A. Serrano Del Castillo, and R. Fernandez-Crehuet Navajas Alzheimer's disease and coffee: a quantitative review Neurol. Res. 29 2007 91 95
155. E. Beghi, E. Pupillo, P. Messina, G. Giussani, and et al. Coffee and amyotrophic lateral sclerosis: a possible preventive role Am. J. Epidemiol. 174 2011 1002 1008
156. K. Saaksjarvi, P. Knekt, H. Rissanen, M.A. Laaksonen, and et al. Prospective study of coffee consumption and risk of Parkinson's disease Eur. J. Clin. Nutr. 62 2007 908 915
157. V. Dostal, C.M. Roberts, and C.D. Link Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of beta-amyloid peptide toxicity Genetics 186 2010 857 866
158. J.H. An, and T.K. Blackwell SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response Genes Dev. 17 2003 1882 1893
159. U. Boettler, N. Volz, G. Pahlke, N. Teller, and et al. Coffees rich in chlorogenic acid or N-methylpyridinium induce chemopreventive phase II-enzymes via the Nrf2/ARE pathway in vitro and in vivo Mol. Nutr. Food Res. 55 2011 798 802
160. E.S. Cho, Y.J. Jang, M.K. Hwang, N.J. Kang, and et al. Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals Mutat. Res. 661 2009 18 24
161. J. Yao, B. Zhang, C. Ge, S. Peng, and J. Fang Xanthohumol: a polyphenol chalcone present in hops, activating Nrf2 enzymes to confer protection against oxidative damage in PC12Cells J. Agric. Food Chem. 63 2015 1521 1531
162. S. Kalayarasan, N. Sriram, A. Sureshkumar, and G. Sudhandiran Chromium (VI)-induced oxidative stress and apoptosis is reduced by garlic and its derivative S-allylcysteine through the activation of Nrf2 in the hepatocytes of Wistar rats J. Appl. Toxicol. 28 2008 908 919
163. Y. Kosuge, Y. Koen, K. Ishige, K. Minami, and et al. S-allyl-l-cysteine selectively protects cultured rat hippocampal neurons from amyloid beta-protein- and tunicamycin-induced neuronal death Neuroscience 122 2003 885 895
164. Y. Ito, Y. Kosuge, T. Sakikubo, K. Horie, and et al. Protective effect of S-allyl-l-cysteine, a garlic compound, on amyloid beta-protein-induced cell death in nerve growth factor-differentiated PC12 cells Neurosci. Res. 46 2003 119 125
165. V. Perez-De La Cruz, C. Gonzalez-Cortes, J. Pedraza-Chaverri, P.D. Maldonado, and et al. Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes Brain Res. Bull. 68 2006 379 383
166. C.Y. Chen, J.H. Jang, M.H. Li, and Y.J. Surh Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells Biochem. Biophys. Res. Commun. 331 2005 993 1000
167. J.H. Jang, and Y.J. Surh Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death Free Radic. Biol. Med. 34 2003 1100 1110
168. B. Wang, J. Sun, Y. Ma, G. Wu, and et al. Resveratrol preserves mitochondrial function, stimulates mitochondrial biogenesis, and attenuates oxidative stress in regulatory T cells of mice fed a high-fat diet J. Food Sci. 79 2014 H1823 H1831
169. A. Quincozes-Santos, L.D. Bobermin, A. Latini, M. Wajner, and et al. Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1 PloS One 8 2013 e64372
170. L. Song, L. Chen, X. Zhang, J. Li, and W. Le Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis Biomed. Res. Int. 2014 2014 483501
171. M.K. Lee, S.J. Kang, M. Poncz, K.J. Song, and K.S. Park Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine Exp. Mol. Med. 39 2007 376 384
172. E.O. Farombi, S. Shrotriya, H.K. Na, S.H. Kim, and Y.J. Surh Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1 Food Chem. Toxicol. 46 2008 1279 1287
173. X.Y. Fu, M.F. Yang, M.Z. Cao, D.W. Li, and et al. Strategy to suppress oxidative damage-induced neurotoxicity in PC12Cells by curcumin: the role of ROS-mediated DNA damage and the MAPK and AKT pathways Mol. Neurobiol. 2014 10.1007/s12035-014-9021-1
174. Q. Sun, N. Jia, W. Wang, H. Jin, and et al. Activation of SIRT1 by curcumin blocks the neurotoxicity of amyloid-beta25-35 in rat cortical neurons Biochem. Biophys. Res. Commun. 448 2014 89 94
175. M.S. Wang, S. Boddapati, S. Emadi, and M.R. Sierks Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model BMC Neurosci. 11 2010 57
176. J. Pan, H. Li, J.-F. Ma, Y.-Y. Tan, and et al. Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction Transl. Neurodegener. 1 2012 16
177. W. Wang, L. Shi, Y. Xie, C. Ma, and et al. SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease Neurosci. Res. 48 2004 195 202
178. R. Sandhir, A. Yadav, A. Mehrotra, A. Sunkaria, and et al. Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease Neuromol. Med. 16 2014 106 118
179. M. Qu, L. Li, C. Chen, M. Li, and et al. Protective effects of lycopene against amyloid beta-induced neurotoxicity in cultured rat cortical neurons Neurosci. Lett. 505 2011 286 290
180. H. Kaur, S. Chauhan, and R. Sandhir Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease Neurochem. Res. 36 2011 1435 1443
181. S. Peng, J. Yao, Y. Liu, D. Duan, and et al. Activation of Nrf2 target enzymes conferring protection against oxidative stress in PC12 cells by ginger principal constituent 6-shogaol Food Funct. 6 2015 2813 2823
182. S.C. Kim, J.R. Lee, and S.J. Park Role of 6-Shogaol in tert-butyl hydroperoxide-induced apoptosis of HepG2Cells Pharmacology 93 2014 137 144